SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Precigen, Inc. – ‘10-K’ for 12/31/23 – ‘EX-31.2’

On:  Tuesday, 3/19/24, at 4:48pm ET   ·   For:  12/31/23   ·   Accession #:  1356090-24-7   ·   File #:  1-36042

Previous ‘10-K’:  ‘10-K’ on 3/6/23 for 12/31/22   ·   Next & Latest:  ‘10-K/A’ on 4/29/24 for 12/31/23   ·   21 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/19/24  Precigen, Inc.                    10-K       12/31/23  117:21M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.18M 
 3: EX-10.10    Material Contract                                   HTML     46K 
 4: EX-10.11    Material Contract                                   HTML     48K 
 2: EX-10.9     Material Contract                                   HTML     42K 
 5: EX-21.1     Subsidiaries List                                   HTML     33K 
 6: EX-23.1     Consent of Expert or Counsel                        HTML     32K 
11: EX-97       Clawback Policy re: Recovery of Erroneously         HTML     51K 
                Awarded Compensation                                             
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     37K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     37K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     34K 
10: EX-32.2     Certification -- §906 - SOA'02                      HTML     34K 
17: R1          Cover Page                                          HTML     98K 
18: R2          Audit Information                                   HTML     38K 
19: R3          Consolidated Balance Sheets                         HTML    149K 
20: R4          Consolidated Balance Sheets (Parenthetical)         HTML     46K 
21: R5          Consolidated Statements of Operations               HTML    159K 
22: R6          Consolidated Statements of Operations               HTML     46K 
                (Parenthetical)                                                  
23: R7          Condensed Consolidated Statements of Comprehensive  HTML     57K 
                Income (Loss)                                                    
24: R8          Consolidated Statements of Shareholders' Equity     HTML    130K 
25: R9          Consolidated Statements of Cash Flows               HTML    165K 
26: R10         Consolidated Statements of Cash Flows               HTML     44K 
                (Reconciliation of Cash)                                         
27: R11         Consolidated Statement of Cash Flows                HTML     34K 
                (Parenthetical)                                                  
28: R12         Organization and Basis of Presentation              HTML     43K 
29: R13         Summary of Significant Accounting Policies          HTML    107K 
30: R14         Discontinued Operations                             HTML     88K 
31: R15         Investments in Joint Ventures                       HTML     41K 
32: R16         Collaboration and Licensing Revenue                 HTML     66K 
33: R17         Short-term and Long-term Investments                HTML     58K 
34: R18         Fair Value Measurements                             HTML     61K 
35: R19         Property, Plant and Equipment, Net                  HTML     49K 
36: R20         Goodwill and Intangible Assets, Net                 HTML     59K 
37: R21         Lines of Credit and Long-Term Debt                  HTML     50K 
38: R22         Income Taxes                                        HTML    121K 
39: R23         Shareholders' Equity                                HTML     50K 
40: R24         Share-Based Payments                                HTML     90K 
41: R25         Commitments and Contingencies                       HTML     41K 
42: R26         Operating Leases                                    HTML     63K 
43: R27         Segments                                            HTML    109K 
44: R28         Defined Contribution Plans                          HTML     35K 
45: R29         Summary of Significant Accounting Policies          HTML    148K 
                (Policies)                                                       
46: R30         Summary of Significant Accounting Policies          HTML     70K 
                (Tables)                                                         
47: R31         Discontinued Operations (Tables)                    HTML     85K 
48: R32         Collaboration and Licensing Revenue (Tables)        HTML     58K 
49: R33         Short-term and Long-term Investments (Tables)       HTML     59K 
50: R34         Fair Value Measurements (Tables)                    HTML     58K 
51: R35         Property, Plant and Equipment, Net (Tables)         HTML     48K 
52: R36         Goodwill and Intangible Assets, Net (Tables)        HTML     65K 
53: R37         Lines of Credit and Long-Term Debt (Tables)         HTML     42K 
54: R38         Income Taxes (Tables)                               HTML    125K 
55: R39         Shareholders' Equity (Tables)                       HTML     40K 
56: R40         Share-Based Payments (Tables)                       HTML     89K 
57: R41         Operating Leases (Tables)                           HTML     64K 
58: R42         Segments (Tables)                                   HTML    105K 
59: R43         Organization and Basis of Presentation -            HTML     63K 
                Additional Information (Details)                                 
60: R44         Summary of Significant Accounting Policies -        HTML     75K 
                Additional Information (Details)                                 
61: R45         Summary of Significant Accounting Policies -        HTML     43K 
                Rollforward of Allowance for Credit Losses                       
                (Details)                                                        
62: R46         Summary of Significant Accounting Policies -        HTML     56K 
                Estimated Useful Lives of Property, Plant and                    
                Equipment (Details)                                              
63: R47         Summary of Significant Accounting Policies -        HTML     60K 
                Summary of Assumptions Used in Option Pricing                    
                Model (Details)                                                  
64: R48         Summary of Significant Accounting Policies -        HTML     43K 
                Potentially Dilutive Securities Excluded from                    
                Calculation of Net Loss per Share (Details)                      
65: R49         Discontinued Operations - Narrative (Details)       HTML     65K 
66: R50         Discontinued Operations - Summary of Financial      HTML     75K 
                Results for Trans Ova (Details)                                  
67: R51         Discontinued Operations - Summary of Significant    HTML     59K 
                Non-Cash Items, Investments and Purchases of                     
                Property, Plant and Equipment on Cash Flows -                    
                Trans Ova (Details)                                              
68: R52         Discontinued Operations - Summary of Financial      HTML     48K 
                Results for MBP Titan (Details)                                  
69: R53         Discontinued Operations - Summary Of Significant    HTML     43K 
                Non-Cash Items, Investments and Purchases of                     
                Property, Plant and Equipment on Cash Flows - MBP                
                Titan (Details)                                                  
70: R54         Investments in Joint Ventures - Intrexon Energy     HTML     52K 
                Partners - Additional Information (Details)                      
71: R55         Investments in Joint Ventures - Intrexon Energy     HTML     52K 
                Partners II - Additional Information (Details)                   
72: R56         Investments in Joint Ventures - Interests in        HTML     42K 
                Intrexon Energy Partners and Intrexon Energy                     
                Partners II (Details)                                            
73: R57         Collaboration and Licensing Revenue - Summarized    HTML     51K 
                Collaboration and Licensing Revenues (Details)                   
74: R58         Collaboration and Licensing Revenue - Additional    HTML     48K 
                Information (Details)                                            
75: R59         Collaboration and Licensing Revenue - Summary of    HTML     46K 
                Deferred Revenue (Details)                                       
76: R60         Short-term and Long-term Investments - Summary of   HTML     55K 
                Amortized Cost, Gross Unrealized Gains and Losses                
                and Fair Value of Investments (Details)                          
77: R61         Short-term and Long-term Investments - Narrative    HTML     35K 
                (Details)                                                        
78: R62         Fair Value Measurements - Summary of Placement in   HTML     60K 
                the Fair Value Hierarchy of Financial Assets that                
                are Measured at Fair Value on a Recurring Basis                  
                (Details)                                                        
79: R63         Fair Value Measurements - Additional Information    HTML     39K 
                (Details)                                                        
80: R64         Property, Plant and Equipment, Net - Schedule of    HTML     57K 
                Property, Plant and Equipment (Details)                          
81: R65         Property, Plant and Equipment, Net - Additional     HTML     40K 
                Information (Details)                                            
82: R66         Goodwill and Intangible Assets, Net - Schedule of   HTML     45K 
                Changes in Carrying Amount of Goodwill (Details)                 
83: R67         Goodwill and Intangible Assets, Net - Additional    HTML     52K 
                Information (Details)                                            
84: R68         Goodwill and Intangible Assets, Net - Schedule of   HTML     47K 
                Intangible Assets (Details)                                      
85: R69         Goodwill and Intangible Assets, Net - Schedule of   HTML     48K 
                Definite-Lived Intangible Assets, Estimated Future               
                Amortization Expense (Details)                                   
86: R70         Lines of Credit and Long-Term Debt - Lines of       HTML     44K 
                Credit - Additional Information (Details)                        
87: R71         Lines of Credit and Long-Term Debt - Short-Term     HTML     67K 
                Debt and Convertible Debt - Additional Information               
                (Details)                                                        
88: R72         Lines of Credit and Long-Term Debt - Components of  HTML     48K 
                Interest Expense (Details)                                       
89: R73         Income Taxes - Components of Loss Before Income     HTML     42K 
                Taxes (Details)                                                  
90: R74         Income Taxes - Components of Income Tax Benefit     HTML     53K 
                (Details)                                                        
91: R75         Income Taxes - Schedule of Effective Income Tax     HTML     61K 
                Rate Reconciliation (Details)                                    
92: R76         Income Taxes - Schedule of Deferred Tax Assets and  HTML     75K 
                Liabilities (Details)                                            
93: R77         Income Taxes - Summary of Valuation Allowance       HTML     47K 
                (Details)                                                        
94: R78         Income Taxes - Additional Information (Details)     HTML     48K 
95: R79         Shareholders' Equity - Additional Information       HTML     54K 
                (Details)                                                        
96: R80         Shareholders' Equity - Components of Accumulated    HTML     54K 
                Other Comprehensive Income (Loss) (Details)                      
97: R81         Share-Based Payments - Schedule of Stock-based      HTML     45K 
                Compensation Expense (Details)                                   
98: R82         Share-Based Payments - Additional Information       HTML     89K 
                (Details)                                                        
99: R83         Share-Based Payments - Schedule of Stock Option     HTML     74K 
                Activity (Details)                                               
100: R84         Share-Based Payments - Schedule of Restricted       HTML     63K  
                Stock Unit Activity (Details)                                    
101: R85         Commitments and Contingencies - Contingencies -     HTML     42K  
                Additional Information (Details)                                 
102: R86         Operating Leases - Additional Information           HTML     40K  
                (Details)                                                        
103: R87         Operating Leases - Components of Lease Costs        HTML     41K  
                (Details)                                                        
104: R88         Operating Leases - Maturities of Lease Liabilities  HTML     56K  
                (Details)                                                        
105: R89         Operating Leases - Lease Terms and Discount Rates   HTML     37K  
                (Details)                                                        
106: R90         Operating Leases - Other Information (Details)      HTML     37K  
107: R91         Segments - Adjusted EBITDA by Reportable Segment    HTML     40K  
                (Details)                                                        
108: R92         Segments - Reconciliation of Net Loss Before        HTML     85K  
                Income Taxes (Details)                                           
109: R93         Segments - Revenues by Reportable Segment           HTML     43K  
                (Details)                                                        
110: R94         Segments - Additional Information (Details)         HTML     50K  
111: R95         Segments - Goodwill (Details)                       HTML     51K  
112: R96         Defined Contribution Plans - Additional             HTML     34K  
                Information (Details)                                            
114: XML         IDEA XML File -- Filing Summary                      XML    216K  
117: XML         XBRL Instance -- pgen-20231231_htm                   XML   2.17M  
113: EXCEL       IDEA Workbook of Financial Report Info              XLSX    206K  
13: EX-101.CAL  XBRL Calculations -- pgen-20231231_cal               XML    286K 
14: EX-101.DEF  XBRL Definitions -- pgen-20231231_def                XML   1.00M 
15: EX-101.LAB  XBRL Labels -- pgen-20231231_lab                     XML   1.93M 
16: EX-101.PRE  XBRL Presentations -- pgen-20231231_pre              XML   1.46M 
12: EX-101.SCH  XBRL Schema -- pgen-20231231                         XSD    221K 
115: JSON        XBRL Instance as JSON Data -- MetaLinks              648±   986K  
116: ZIP         XBRL Zipped Folder -- 0001356090-24-000007-xbrl      Zip   3.11M  


‘EX-31.2’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  

Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Harry Thomasian Jr., certify that:
1.I have reviewed this Annual Report on Form 10-K of Precigen, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: March 19, 2024
 
/s/    HARRY THOMASIAN JR.        
Chief Financial Officer
(Principal Financial Officer)


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/19/248-K
For Period end:12/31/23
 List all Filings 


21 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/09/23  Precigen, Inc.                    10-Q        6/30/23   93:17M
 7/06/23  Precigen, Inc.                    S-8         7/06/23    5:212K                                   Davis Polk & … LLP 01/FA
11/09/20  Precigen, Inc.                    10-Q        9/30/20  117:12M
 6/22/20  Precigen, Inc.                    S-3                    7:747K                                   Donnelley … Solutions/FA
 6/19/20  Precigen, Inc.                    8-K:5,9     6/19/20   11:175K                                   Donnelley … Solutions/FA
 6/04/20  Precigen, Inc.                    8-K:5,9     6/03/20   11:295K                                   Donnelley … Solutions/FA
 5/11/20  Precigen, Inc.                    10-Q        3/31/20  111:10M
 3/02/20  Precigen, Inc.                    10-K       12/31/19  141:33M                                    Workiva Inc Wde… FA01/FA
 2/04/20  Precigen, Inc.                    8-K:2,5,8,9 1/30/20   13:379K                                   Donnelley … Solutions/FA
 1/07/20  Precigen, Inc.                    8-K:5,9     1/01/20   11:240K                                   Donnelley … Solutions/FA
 8/09/19  Precigen, Inc.                    10-Q        6/30/19  116:12M
 6/12/19  Precigen, Inc.                    8-K:5,9     6/12/19    2:43K                                    Donnelley … Solutions/FA
 5/09/19  Precigen, Inc.                    10-Q        3/31/19  109:8.9M
 6/08/18  Precigen, Inc.                    8-K:5,9     6/07/18    2:36K                                    Donnelley … Solutions/FA
 3/01/18  Precigen, Inc.                    10-K       12/31/17  138:16M
 6/30/17  Precigen, Inc.                    8-K:5,9     6/28/17    2:35K                                    Donnelley … Solutions/FA
 6/13/16  Precigen, Inc.                    8-K:5,9     6/09/16    2:29K                                    Donnelley … Solutions/FA
 6/17/15  Precigen, Inc.                    8-K:5,9     6/11/15    3:101K                                   Donnelley … Solutions/FA
 1/14/15  Precigen, Inc.                    8-K:1,3,9   1/09/15    6:489K                                   Donnelley … Solutions/FA
 6/13/14  Precigen, Inc.                    8-K:5,9     6/09/14    5:407K                                   Donnelley … Solutions/FA
 7/29/13  Precigen, Inc.                    S-1/A                 15:5.3M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001356090-24-000007   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 12, 8:17:38.2pm ET